National Association of Testing Authorities, Australia
Scope of Accreditation
CSL Innovation - Research and Clinical Bioanalytics
Site
Research and Clinical Bioanalytics
Accreditation No.
19546
Site No.
23335
Date of Accreditation
12 Aug 2016
Address
Bio21 Institute, Nancy Millis Building, Level 4, 30 Flemington Road
University Of Melbourne, VIC 3010
Australia
Contact
Ms Roslyn Davis
P: +61 0412664286
Availability
Services not available to external clients
Scope of Accreditation
Research and Clinical Bioanalytics
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
| Service | Product | Determinant | Technique |
|---|---|---|---|
| Analysis in support of clinical trials and/or pre-clinical studies | Animal biological samples; Human biological samples | Anti-drug antibodies measurement; Concentration of drug and/or biological agents; Evaluation of candidate biologic therapeutics and their impact on disease and treatment outcomes | Electrochemiluminescence (ECL); Enzyme linked immunosorbent assay (ELISA); Flow cytometry - Cell phenotyping, receptor occupancy assay; LC-MS-MS; Multiplex assays |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
19546
Site No.
23335
Print date
25 Apr 2024
END OF SCOPE
